Publication Name	World Journal of Diabetes
Manuscript ID	26149
Country	India

Received	2016-03-30 11:00
Peer-Review Started	2016-03-31 11:48
To Make the First Decision	2016-05-16 10:53
Return for Revision	2016-05-17 15:55
Revised	2016-05-30 00:00
Second Decision	2016-06-12 10:21
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-06-29 09:44
Articles in Press	2016-06-29 09:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-08-04 22:09
Publish the Manuscript Online	2016-08-09 11:33

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Genetics & Heredity
Manuscript Type	Review
Article Title	Pharmacogenetic studies update in type 2 diabetes mellitus
Manuscript Source	Invited Manuscript
All Author List	Shalini Singh, Kauser Usman and Monisha Banerjee
Funding Agency and Grant Number
Corresponding Author	Dr. Monisha Banerjee, Professor, Molecular and Human Genetics Laboratory, Department of Zoology, University of Lucknow, University Road, Lucknow 226007, India. banerjee_monisha30@rediffmail.com
Key Words	Type 2 diabetes mellitus; Pharmacogenetics; Genetic variants; Oral antidiabetic drugs; Personalized medicine
Core Tip	Type 2 diabetes mellitus (T2DM) is a highly prevalent metabolic disorder, characterized by chronic hyperglycemia. It results from an interaction of environ-mental as well as genetic factors. Several genes have been identified associated with disease develop-ment and therapeutic outcomes. Inter-individual varia-tions in the human genome affect both, risk of T2DM deve-lop-ment and personalized response to identical drug therapies. Pharmacogenetic approaches focus on single nucleotide polymorphisms and their influence on individual drug response, efficacy and toxicity. In the present study, an effort has been made to review the genetic polymorphisms in candidate genes associated with efficacy of oral antidiabetic drugs.
Publish Date	2016-08-09 11:33
Citation	Singh S, Usman K, Banerjee M. Pharmacogenetic studies update in type 2 diabetes mellitus. World J Diabetes 2016; 7(15): 302-315
URL	http://www.wjgnet.com/1948-9358/full/v7/i15/302.htm
DOI	http://dx.doi.org/10.4239/wjd.v7.i15.302

Full Article (PDF)	WJD-7-302.pdf
Full Article (Word)	WJD-7-302.doc
Manuscript File	26149-Review.doc
Answering Reviewers	26149-Answering reviewers.pdf
Audio Core Tip	26149-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	26149-Conflict-of-interest statement.pdf
Copyright License Agreement	26149-Copyright assignment.pdf
Peer-review Report	26149-Peer-review(s).pdf
Scientific Misconduct Check	26149-Scientific misconduct check.pdf
Scientific Editor Work List	26149-Scientific editor work list.pdf